Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Evaluate the safety and tolerability of escalating oral doses of YM150 in patients undergoing elective primary total knee replacement surgery
Epistemonikos ID: 11465c42c4168ea554372b92e7ab4dc2fb70f6fb
First added on: May 04, 2024